Growth Metrics

Neurocrine Biosciences (NBIX) Shares Outstanding: 2010-2021

Historic Shares Outstanding for Neurocrine Biosciences (NBIX) over the last 4 years, with Sep 2021 value amounting to $94.8 million.

  • Neurocrine Biosciences' Shares Outstanding rose 1.50% to $94.8 million in Q3 2021 from the same period last year, while for Sep 2021 it was $94.8 million, marking a year-over-year increase of 1.50%. This contributed to the annual value of $93.5 million for FY2020, which is 1.30% up from last year.
  • Neurocrine Biosciences' Shares Outstanding amounted to $94.8 million in Q3 2021, which was up 0.21% from $94.6 million recorded in Q2 2021.
  • Over the past 5 years, Neurocrine Biosciences' Shares Outstanding peaked at $94.8 million during Q3 2021, and registered a low of $88.8 million during Q4 2017.
  • Its 3-year average for Shares Outstanding is $93.1 million, with a median of $93.2 million in 2020.
  • Data for Neurocrine Biosciences' Shares Outstanding shows a peak YoY climbed of 2.25% (in 2018) over the last 5 years.
  • Quarterly analysis of 5 years shows Neurocrine Biosciences' Shares Outstanding stood at $88.8 million in 2017, then increased by 2.25% to $90.8 million in 2018, then rose by 1.65% to $92.3 million in 2019, then grew by 1.30% to $93.5 million in 2020, then climbed by 1.50% to $94.8 million in 2021.
  • Its Shares Outstanding stands at $94.8 million for Q3 2021, versus $94.6 million for Q2 2021 and $94.5 million for Q1 2021.